Atrion Corporation (NASDAQ:ATRI) Downgraded by BidaskClub
BidaskClub lowered shares of Atrion Corporation (NASDAQ:ATRI) from a strong-buy rating to a buy rating in a report published on Thursday.
Shares of Atrion Corporation (NASDAQ ATRI) traded down 0.42% during trading on Thursday, hitting $633.00. 443 shares of the company’s stock were exchanged. The firm has a market capitalization of $1.16 billion, a PE ratio of 38.44 and a beta of 0.91. The stock’s 50 day moving average is $620.11 and its 200 day moving average is $526.38. Atrion Corporation has a 1-year low of $393.95 and a 1-year high of $691.95.
In related news, Chairman Emile A. Battat sold 100 shares of the business’s stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $585.50, for a total transaction of $58,550.00. Following the transaction, the chairman now directly owns 149,081 shares of the company’s stock, valued at $87,286,925.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Emile A. Battat sold 655 shares of the business’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $546.31, for a total transaction of $357,833.05. Following the transaction, the chairman now directly owns 151,297 shares in the company, valued at $82,655,064.07. The disclosure for this sale can be found here. Insiders have sold 3,392 shares of company stock worth $1,900,070 over the last ninety days. 24.23% of the stock is currently owned by insiders.
Atrion Corporation Company Profile
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.